Global Angiotensin Receptor Antagonists Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

October 2018 | 119 pages | ID: GF72B0866CCGEN
GlobalInfoResearch

Abstracts

Angiotensin II receptor antagonists are a group of pharmaceuticals that modulate the renin?angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.

SCOPE OF THE REPORT:

The worldwide market for Angiotensin Receptor Antagonists is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Angiotensin Receptor Antagonists in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Pfizer
• Novartis
• Merck
• Astra Zeneca
• Jhonson and Johnson
• Eli Lilly and Company
• Sanofi SA
• Bristol-Myers Squibb
• Bayer
• GSK
• Teva Pharmaceutical

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Valsartan
• Telmisartan
• Losartan
• Irbesartan
• Azilsartan
• Olmesartan

Market Segment by Applications, can be divided into

• Hypertension
• Cardiovascular Diseases
• Kidney Diseases
• Other

There are 15 Chapters to deeply display the global Angiotensin Receptor Antagonists market.

Chapter 1, to describe Angiotensin Receptor Antagonists Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Angiotensin Receptor Antagonists, with sales, revenue, and price of Angiotensin Receptor Antagonists, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Angiotensin Receptor Antagonists, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Angiotensin Receptor Antagonists market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Angiotensin Receptor Antagonists sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Angiotensin Receptor Antagonists Introduction
1.2 Market Analysis by Type
  1.2.1 Valsartan
  1.2.2 Telmisartan
  1.2.3 Losartan
  1.2.4 Irbesartan
  1.2.5 Azilsartan
  1.2.6 Olmesartan
1.3 Market Analysis by Applications
  1.3.1 Hypertension
  1.3.2 Cardiovascular Diseases
  1.3.3 Kidney Diseases
  1.3.4 Other
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Angiotensin Receptor Antagonists Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
  2.2.1 Business Overview
  2.2.2 Angiotensin Receptor Antagonists Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Novartis Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
  2.3.1 Business Overview
  2.3.2 Angiotensin Receptor Antagonists Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Merck Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Astra Zeneca
  2.4.1 Business Overview
  2.4.2 Angiotensin Receptor Antagonists Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Astra Zeneca Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Jhonson and Johnson
  2.5.1 Business Overview
  2.5.2 Angiotensin Receptor Antagonists Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly and Company
  2.6.1 Business Overview
  2.6.2 Angiotensin Receptor Antagonists Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Eli Lilly and Company Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi SA
  2.7.1 Business Overview
  2.7.2 Angiotensin Receptor Antagonists Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Sanofi SA Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bristol-Myers Squibb
  2.8.1 Business Overview
  2.8.2 Angiotensin Receptor Antagonists Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bayer
  2.9.1 Business Overview
  2.9.2 Angiotensin Receptor Antagonists Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Bayer Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 GSK
  2.10.1 Business Overview
  2.10.2 Angiotensin Receptor Antagonists Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 GSK Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Teva Pharmaceutical
  2.11.1 Business Overview
  2.11.2 Angiotensin Receptor Antagonists Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ANGIOTENSIN RECEPTOR ANTAGONISTS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Angiotensin Receptor Antagonists Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Angiotensin Receptor Antagonists Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Angiotensin Receptor Antagonists Manufacturer Market Share in 2017
  3.3.2 Top 6 Angiotensin Receptor Antagonists Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET ANALYSIS BY REGIONS

4.1 Global Angiotensin Receptor Antagonists Sales, Revenue and Market Share by Regions
  4.1.1 Global Angiotensin Receptor Antagonists Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Angiotensin Receptor Antagonists Revenue and Market Share by Regions (2013-2018)
4.2 North America Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
4.3 Europe Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
4.5 South America Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)

5 NORTH AMERICA ANGIOTENSIN RECEPTOR ANTAGONISTS BY COUNTRIES

5.1 North America Angiotensin Receptor Antagonists Sales, Revenue and Market Share by Countries
  5.1.1 North America Angiotensin Receptor Antagonists Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Angiotensin Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
5.2 United States Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
5.3 Canada Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
5.4 Mexico Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)

6 EUROPE ANGIOTENSIN RECEPTOR ANTAGONISTS BY COUNTRIES

6.1 Europe Angiotensin Receptor Antagonists Sales, Revenue and Market Share by Countries
  6.1.1 Europe Angiotensin Receptor Antagonists Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Angiotensin Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
6.2 Germany Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
6.3 UK Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
6.4 France Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
6.5 Russia Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
6.6 Italy Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC ANGIOTENSIN RECEPTOR ANTAGONISTS BY COUNTRIES

7.1 Asia-Pacific Angiotensin Receptor Antagonists Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Angiotensin Receptor Antagonists Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Angiotensin Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
7.2 China Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
7.3 Japan Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
7.4 Korea Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
7.5 India Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA ANGIOTENSIN RECEPTOR ANTAGONISTS BY COUNTRIES

8.1 South America Angiotensin Receptor Antagonists Sales, Revenue and Market Share by Countries
  8.1.1 South America Angiotensin Receptor Antagonists Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Angiotensin Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
8.3 Argentina Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
8.4 Colombia Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA ANGIOTENSIN RECEPTOR ANTAGONISTS BY COUNTRIES

9.1 Middle East and Africa Angiotensin Receptor Antagonists Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Angiotensin Receptor Antagonists Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Angiotensin Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
9.3 UAE Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
9.4 Egypt Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
9.5 Nigeria Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
9.6 South Africa Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)

10 GLOBAL ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET SEGMENT BY TYPE

10.1 Global Angiotensin Receptor Antagonists Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Angiotensin Receptor Antagonists Sales and Market Share by Type (2013-2018)
  10.1.2 Global Angiotensin Receptor Antagonists Revenue and Market Share by Type (2013-2018)
10.2 Valsartan Sales Growth and Price
  10.2.1 Global Valsartan Sales Growth (2013-2018)
  10.2.2 Global Valsartan Price (2013-2018)
10.3 Telmisartan Sales Growth and Price
  10.3.1 Global Telmisartan Sales Growth (2013-2018)
  10.3.2 Global Telmisartan Price (2013-2018)
10.4 Losartan Sales Growth and Price
  10.4.1 Global Losartan Sales Growth (2013-2018)
  10.4.2 Global Losartan Price (2013-2018)
10.5 Irbesartan Sales Growth and Price
  10.5.1 Global Irbesartan Sales Growth (2013-2018)
  10.5.2 Global Irbesartan Price (2013-2018)
10.6 Azilsartan Sales Growth and Price
  10.6.1 Global Azilsartan Sales Growth (2013-2018)
  10.6.2 Global Azilsartan Price (2013-2018)
10.7 Olmesartan Sales Growth and Price
  10.7.1 Global Olmesartan Sales Growth (2013-2018)
  10.7.2 Global Olmesartan Price (2013-2018)

11 GLOBAL ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET SEGMENT BY APPLICATION

11.1 Global Angiotensin Receptor Antagonists Sales Market Share by Application (2013-2018)
11.2 Hypertension Sales Growth (2013-2018)
11.3 Cardiovascular Diseases Sales Growth (2013-2018)
11.4 Kidney Diseases Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)

12 ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET FORECAST (2018-2023)

12.1 Global Angiotensin Receptor Antagonists Sales, Revenue and Growth Rate (2018-2023)
12.2 Angiotensin Receptor Antagonists Market Forecast by Regions (2018-2023)
  12.2.1 North America Angiotensin Receptor Antagonists Market Forecast (2018-2023)
  12.2.2 Europe Angiotensin Receptor Antagonists Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Angiotensin Receptor Antagonists Market Forecast (2018-2023)
  12.2.4 South America Angiotensin Receptor Antagonists Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Angiotensin Receptor Antagonists Market Forecast (2018-2023)
12.3 Angiotensin Receptor Antagonists Market Forecast by Type (2018-2023)
  12.3.1 Global Angiotensin Receptor Antagonists Sales Forecast by Type (2018-2023)
  12.3.2 Global Angiotensin Receptor Antagonists Market Share Forecast by Type (2018-2023)
12.4 Angiotensin Receptor Antagonists Market Forecast by Application (2018-2023)
  12.4.1 Global Angiotensin Receptor Antagonists Sales Forecast by Application (2018-2023)
  12.4.2 Global Angiotensin Receptor Antagonists Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Angiotensin Receptor Antagonists Picture
Table Product Specifications of Angiotensin Receptor Antagonists
Figure Global Sales Market Share of Angiotensin Receptor Antagonists by Types in 2017
Table Angiotensin Receptor Antagonists Types for Major Manufacturers
Figure Valsartan Picture
Figure Telmisartan Picture
Figure Losartan Picture
Figure Irbesartan Picture
Figure Azilsartan Picture
Figure Olmesartan Picture
Figure Angiotensin Receptor Antagonists Sales Market Share by Applications in 2017
Figure Hypertension Picture
Figure Cardiovascular Diseases Picture
Figure Kidney Diseases Picture
Figure Other Picture
Figure United States Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure France Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure UK Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure China Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure India Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Angiotensin Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Angiotensin Receptor Antagonists Type and Applications
Table Pfizer Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Angiotensin Receptor Antagonists Type and Applications
Table Novartis Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Angiotensin Receptor Antagonists Type and Applications
Table Merck Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table Astra Zeneca Angiotensin Receptor Antagonists Type and Applications
Table Astra Zeneca Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table Jhonson and Johnson Angiotensin Receptor Antagonists Type and Applications
Table Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Angiotensin Receptor Antagonists Type and Applications
Table Eli Lilly and Company Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi SA Basic Information, Manufacturing Base and Competitors
Table Sanofi SA Angiotensin Receptor Antagonists Type and Applications
Table Sanofi SA Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Angiotensin Receptor Antagonists Type and Applications
Table Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Angiotensin Receptor Antagonists Type and Applications
Table Bayer Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Angiotensin Receptor Antagonists Type and Applications
Table GSK Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Angiotensin Receptor Antagonists Type and Applications
Table Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Angiotensin Receptor Antagonists Sales by Manufacturer (2016-2017)
Figure Global Angiotensin Receptor Antagonists Sales Market Share by Manufacturer in 2016
Figure Global Angiotensin Receptor Antagonists Sales Market Share by Manufacturer in 2017
Table Global Angiotensin Receptor Antagonists Revenue by Manufacturer (2016-2017)
Figure Global Angiotensin Receptor Antagonists Revenue Market Share by Manufacturer in 2016
Figure Global Angiotensin Receptor Antagonists Revenue Market Share by Manufacturer in 2017
Figure Top 3 Angiotensin Receptor Antagonists Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Angiotensin Receptor Antagonists Manufacturer (Revenue) Market Share in 2017
Figure Global Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Global Angiotensin Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Global Angiotensin Receptor Antagonists Sales by Regions (2013-2018)
Table Global Angiotensin Receptor Antagonists Sales Market Share by Regions (2013-2018)
Table Global Angiotensin Receptor Antagonists Revenue by Regions (2013-2018)
Figure Global Angiotensin Receptor Antagonists Revenue Market Share by Regions in 2013
Figure Global Angiotensin Receptor Antagonists Revenue Market Share by Regions in 2017
Figure North America Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Europe Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure South America Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure North America Angiotensin Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table North America Angiotensin Receptor Antagonists Sales by Countries (2013-2018)
Table North America Angiotensin Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure North America Angiotensin Receptor Antagonists Sales Market Share by Countries in 2013
Figure North America Angiotensin Receptor Antagonists Sales Market Share by Countries in 2017
Table North America Angiotensin Receptor Antagonists Revenue by Countries (2013-2018)
Table North America Angiotensin Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure North America Angiotensin Receptor Antagonists Revenue Market Share by Countries in 2013
Figure North America Angiotensin Receptor Antagonists Revenue Market Share by Countries in 2017
Figure United States Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Canada Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Mexico Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Europe Angiotensin Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Europe Angiotensin Receptor Antagonists Sales by Countries (2013-2018)
Table Europe Angiotensin Receptor Antagonists Sales Market Share by Countries (2013-2018)
Table Europe Angiotensin Receptor Antagonists Revenue by Countries (2013-2018)
Figure Europe Angiotensin Receptor Antagonists Revenue Market Share by Countries in 2016
Figure Europe Angiotensin Receptor Antagonists Revenue Market Share by Countries in 2017
Figure Germany Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure UK Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure France Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Russia Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Italy Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Angiotensin Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Angiotensin Receptor Antagonists Sales by Countries (2013-2018)
Table Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share by Countries 2017
Table Asia-Pacific Angiotensin Receptor Antagonists Revenue by Countries (2013-2018)
Figure Asia-Pacific Angiotensin Receptor Antagonists Revenue Market Share by Countries 2017
Figure China Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Japan Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Korea Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure India Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Southeast Asia Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure South America Angiotensin Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table South America Angiotensin Receptor Antagonists Sales by Countries (2013-2018)
Table South America Angiotensin Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure South America Angiotensin Receptor Antagonists Sales Market Share by Countries in 2017
Table South America Angiotensin Receptor Antagonists Revenue by Countries (2013-2018)
Table South America Angiotensin Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure South America Angiotensin Receptor Antagonists Revenue Market Share by Countries in 2017
Figure Brazil Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Argentina Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Colombia Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Angiotensin Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Angiotensin Receptor Antagonists Sales by Countries (2013-2018)
Table Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share by Countries in 2017
Table Middle East and Africa Angiotensin Receptor Antagonists Revenue by Countries (2013-2018)
Table Middle East and Africa Angiotensin Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Angiotensin Receptor Antagonists Revenue Market Share by Countries in 2013
Figure Middle East and Africa Angiotensin Receptor Antagonists Revenue Market Share by Countries in 2017
Figure Saudi Arabia Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure UAE Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Egypt Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Nigeria Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure South Africa Angiotensin Receptor Antagonists Sales and Growth Rate (2013-2018)
Table Global Angiotensin Receptor Antagonists Sales by Type (2013-2018)
Table Global Angiotensin Receptor Antagonists Sales Share by Type (2013-2018)
Table Global Angiotensin Receptor Antagonists Revenue by Type (2013-2018)
Table Global Angiotensin Receptor Antagonists Revenue Share by Type (2013-2018)
Figure Global Valsartan Sales Growth (2013-2018)
Figure Global Valsartan Price (2013-2018)
Figure Global Telmisartan Sales Growth (2013-2018)
Figure Global Telmisartan Price (2013-2018)
Figure Global Losartan Sales Growth (2013-2018)
Figure Global Losartan Price (2013-2018)
Figure Global Irbesartan Sales Growth (2013-2018)
Figure Global Irbesartan Price (2013-2018)
Figure Global Azilsartan Sales Growth (2013-2018)
Figure Global Azilsartan Price (2013-2018)
Figure Global Olmesartan Sales Growth (2013-2018)
Figure Global Olmesartan Price (2013-2018)
Table Global Angiotensin Receptor Antagonists Sales by Application (2013-2018)
Table Global Angiotensin Receptor Antagonists Sales Share by Application (2013-2018)
Figure Global Cardiovascular Diseases Sales Growth (2013-2018)
Figure Global Kidney Diseases Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Angiotensin Receptor Antagonists Sales, Revenue and Growth Rate (2018-2023)
Table Global Angiotensin Receptor Antagonists Sales Forecast by Regions (2018-2023)
Table Global Angiotensin Receptor Antagonists Market Share Forecast by Regions (2018-2023)
Figure North America Sales Angiotensin Receptor Antagonists Market Forecast (2018-2023)
Figure Europe Sales Angiotensin Receptor Antagonists Market Forecast (2018-2023)
Figure Asia-Pacific Sales Angiotensin Receptor Antagonists Market Forecast (2018-2023)
Figure South America Sales Angiotensin Receptor Antagonists Market Forecast (2018-2023)
Figure Middle East and Africa Sales Angiotensin Receptor Antagonists Market Forecast (2018-2023)
Table Global Angiotensin Receptor Antagonists Sales Forecast by Type (2018-2023)
Table Global Angiotensin Receptor Antagonists Market Share Forecast by Type (2018-2023)
Table Global Angiotensin Receptor Antagonists Sales Forecast by Application (2018-2023)
Table Global Angiotensin Receptor Antagonists Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List